AstraZeneca’s US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025July 29, 2025
Share Facebook Twitter LinkedIn Pinterest Email Eric Rutkoske, Guggenheim global head of M&A, joins ‘Money Movers’ to discuss what’s driving the jump in M&A in Europe, the mixed signals Rutkoske is seeing, and more.